We’re conducting a survey of compounding pharmacies to help APC understand your readiness for compliance with GFI #256 so that we can advise FDA about whether an enforcement delay is warranted.
Don't wait too much longer to register for CCH 2022, as the APC room block at the Hilton National Mall is filling up fast, and there’s no overflow hotel.
As required under its Bylaws, the 2022 annual meeting of the Alliance for Pharmacy Compounding will be held on Wednesday, September 14, 2:00-2:30pm.
Congressman Buddy Carter (GA) and Congresswoman Diana Harshbarger (TN) respectfully requested in a letter that CVM and FDA delay enforcement of GFI #256 until at least FY2024.
Please consider joining one of our boards in 2023.
All APC members who compound hormones for their patients are urged to attend.
One-pagers help you help prescribers understand compounding.
Last week, we asked for your help in encouraging physicians to sign our letter to FDA expressing concern about its implicit threat to restrict cBHT—and you heard the call and answered.
APC has confirmed that two members of Congress who serve on key committees with oversight over pharmacy compounding in the U.S. Senate and House will speak at Compounders on Capitol Hill.
A joint APC-NCPA letter submitted last week to FDA Center for Veterinary Medicine’s Dr. Bill Flynn includes more than 2 dozen questions on which the associations seek great clarity regarding the agency’s animal compounding GFI.
FOLLOW US
